Kerry Dooley Young and Liz Seegert
Authored Posts
-
4 tips for reporting on press releasesabout new study results for drugs
Many reporters on the health beat face tight deadlines to publish stories based on press releases from the pharmaceutical industry…
-
Panel to explore risk factors, management and challenges of Alzheimer’s disease
The Centers for Medicare and Medicaid (CMS) finalized its decision to cover the controversial Alzheimer’s drug Aduhelm earlier this month — delighting…
-
Biden’s bid for a nursing home vaccine mandate faces obstacles
EDITOR’S NOTE: This is the second in a series about the Biden Administration’s efforts to increase COVID-19 vaccination rates among…
-
Disease-awareness campaigns merit extra scrutiny, experts say
This is part 2 of a package on sponsored disease awareness campaigns and other controversial drug marketing practices, focusing on…
-
Explaining Biogen’s controversial ‘MCI’ advertising to your audience
New marketing campaigns about forgetfulness and distraction could lead people to seek the costly Aduhelm drug for Alzheimer’s disease even…